A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier - Wikidata - awgldk - TriplyDB

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

http://www.wikidata.org/entity/Q28472987

about

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brain Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment.Agile delivery of protein therapeutics to CNS Lysolipid containing liposomes for transendothelial drug delivery Novel treatment strategies for brain tumors and metastases.New strategies to deliver anticancer drugs to brain tumors.Receptor-Mediated Drug Delivery Systems Targeting to Glioma Macromolecular drug transport into the brain using targeted therapy.Receptor-mediated therapeutic transport across the blood-brain barrier.Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.Developing therapeutic antibodies for neurodegenerative disease.Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier.Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future.Re-engineering therapeutic antibodies for Alzheimer's disease as blood-brain barrier penetrating bi-specific antibodies.D-Peptides as Recognition Molecules and Therapeutic Agents.Structurally distinct hybrid polymer/lipid nanoconstructs harboring a type-I ribotoxin as cellular imaging and glioblastoma-directed therapeutic vectors.Non-invasive synergistic treatment of brain tumors by targeted chemotherapeutic delivery and amplified focused ultrasound-hyperthermia using magnetic nanographene oxide.Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study.Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy.Drug transport across the blood-brain barrier

P2860

Q21223671-79F1A348-4C3F-44FE-8221-8D50170C8F52 Q26778701-7CF13D08-A45D-49D0-A80D-DECDE7240EA1 Q27311201-C3D3879E-671B-4150-9C05-447C8673E05A Q27331875-20E7D455-0F12-4BB3-ABE0-CC71ABA3FD64 Q30474002-0BDD2D49-8FD8-4766-99E1-F5FEAB5D0B3C Q34079647-8BE31E82-2E49-4EFC-BCCB-C6B555D29962 Q34227171-78E4DBE0-8C3D-4242-9E8F-92C96693E92F Q35734471-A935E141-0612-4098-B137-EFC3C1676E0F Q37364700-24877E49-EAA8-47BB-A12B-35865D870F2A Q37636271-BBF99729-2D1E-42BC-AF02-0DA25C3978A1 Q37656514-7F270C96-9553-496D-8350-0E28E61EF7DC Q37773246-FFDFBFD9-B53A-448D-934A-C0E9B2EBE1EA Q37855817-E155BFB9-5942-47A8-8FD8-CCCE620B6E65 Q38095360-1E30145D-2405-4EAA-B5BE-3FD73A2A76AA Q38269392-F91DE992-E6AE-40F6-9274-A5F566827837 Q38401892-4225D497-B712-4927-B09F-0DF5967CD3A5 Q38634722-CCDFE163-A880-49CD-B621-95C7675A1FA5 Q38826744-C8A16E0F-29A4-4659-BAAA-714F1EB4901C Q38851989-0497BF6E-03A8-4F89-A409-21B7AE60B4C0 Q38960506-E73EC3D9-1191-439E-A70C-BE5CA807BAE3 Q39146745-A526A1C9-0B1E-4B77-9877-1D223738E4A3 Q40060003-65D8C586-EC50-4E22-BF25-5835013B2EA0 Q44844636-EB61F873-EEDF-420E-B0EE-F010AB131CBD Q47931787-FC562D57-3B6C-46A2-8963-4FD5F0E1CAED Q57677287-AA4F250E-8267-4C73-9C59-28414946A3B6

P2860

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

http://www.wikidata.org/entity/Q28472987

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

@ast

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

@en

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

@nl

type

label

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

@ast

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

@en

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

@nl

prefLabel

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

@ast

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

@en

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

@nl

P1433

Q28472987-4D733565-E1FC-43EA-892A-A5355E9BAA23

P1476

Q28472987-0A3FFDE3-F7E5-4060-A1AD-79E97B28BDBE

P2093

Q28472987-0AE0AD76-1F03-4F89-AD8F-55B2DF2EF252

Q28472987-4C5F9953-82A0-4C39-A8F1-52B1138A7758

Q28472987-79C9CCBF-A156-4392-81DE-6259895ED130

Q28472987-7DB504F7-C00D-4BBE-A655-45C702CECB2B

Q28472987-9453239F-C50C-4B8D-BAC9-595D85CB2C01

Q28472987-964FE62D-6F9F-4CA8-980E-F6FEF806C480

Q28472987-A25194B4-7D20-4324-B328-7D2C34492167

Q28472987-A61D5F08-DB4C-4F95-9F73-087E4C71DAFB

Q28472987-B3DA9B97-4A03-4E86-902B-9154973D2C1C

Q28472987-D1C5B0B1-562A-44B7-86A1-2F4CDD7C7D16

P2860

Q28472987-00CE5EA5-6396-4B18-AEA8-B12F3F91BEAB

Q28472987-01ED35C7-3E8C-4527-AE23-F789C1642FA5

Q28472987-02F771EE-64EC-4E74-AA80-BC1D0AB5C9E7

Q28472987-051AC98C-BF49-44D4-A5FF-4680C6413D24

Q28472987-07B20766-E53A-4D50-A9DA-D1B30BCA777C

Q28472987-0B856254-2D6D-4231-8B21-76BAE447B83E

Q28472987-1907287F-0EEB-42D9-9491-98D1B0DFCD78

Q28472987-1A9BDABF-2E36-479A-ABE5-BA889B4B37ED

Q28472987-1CD1A329-1AAC-48CA-8AF5-AD04C69E61CF

Q28472987-1D40E684-BA16-4E30-9DDF-18739930B720

P304

Q28472987-68BABE4F-ED31-4402-AA02-4C781BA02A9B

P31

Q28472987-599AF2DC-0FE9-42A2-8504-EB081825C05B

P356

Q28472987-A05F4A25-8BF2-4B73-991E-FAF23D0AD3F6

P407

Q28472987-9D5C1DEB-B261-495E-A987-198BFE48F6DB

P433

Q28472987-0215134C-29C5-44F4-8A19-0917E6CBD770

P478

Q28472987-B8DDAB5A-EB8F-48AF-8601-B135AD4989FD

P577

Q28472987-9298793B-6295-4136-8E0C-DEAA92D0E843

P5875

Q28472987-FEDEB492-2A2E-4995-A38A-6FFC56A35ABD

P698

Q28472987-B4B2A3E7-A188-4A73-8BC8-4EF481F0D96F

P921

Q28472987-6C32FE96-0103-4D87-8061-B8B64B7BB223

Q28472987-C0C8CB36-EDF5-4595-AAEC-334E257E3950

P932

Q28472987-1BAAB959-1BFA-43A9-9E60-3774831E7C22

P356

JOURNAL.PONE.0002469

P1433

P1476

A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier

@en

P2093

Cheryl Pfeifer

http://www.w3.org/2001/XMLSchema#string

Delara Karkan

http://www.w3.org/2001/XMLSchema#string

Gavin Arthur

http://www.w3.org/2001/XMLSchema#string

Gerrasimo Koliatis

http://www.w3.org/2001/XMLSchema#string

Maki Ujiie

http://www.w3.org/2001/XMLSchema#string

Qingqi Chen

http://www.w3.org/2001/XMLSchema#string

Reinhard Gabathuler

http://www.w3.org/2001/XMLSchema#string

Sam Tsai

http://www.w3.org/2001/XMLSchema#string

Timothy Z Vitalis

http://www.w3.org/2001/XMLSchema#string

Wilfred A Jefferies

http://www.w3.org/2001/XMLSchema#string

P2860

Junctions between intimately apposed cell membranes in the vertebrate brain

High transcytosis of melanotransferrin (P97) across the blood-brain barrier

Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

First total synthesis of taxol. 1. Functionalization of the B ring

Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.

Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy.

Paclitaxel metabolites in human plasma and urine: identification of 6 alpha-hydroxytaxol, 7-epitaxol and taxol hydrolysis products using liquid chromatography/atmospheric-pressure chemical ionization mass spectrometry.

Barrier mechanisms in the brain, I. Adult brain.

Barrier mechanisms in the brain, II. Immature brain.

P304

e2469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0002469

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5279914

http://www.w3.org/2001/XMLSchema#string

P698

18575595

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

P932

2424243

http://www.w3.org/2001/XMLSchema#string